ImmueMed
Contact Us
KO
Company
Company Introduction
CEO Greeting
Organizational Status
Mission & Business Strategy
Direction
R & D
Antiviral Agent
Research Projects
Pipeline
Company News
Publicity
Investment Information
Notice
Financial Information
Investment Inquiry
Company
Company Introduction
CEO Greeting
Organizational Status
Mission & Business Strategy
Direction
R & D
Antiviral Agent
Research Projects
Pipeline
Company News
Publicity
Investment Information
Notice
Financial Information
Investment Inquiry
Overall Menu
Company
Company
Introduction
CEO Greeting
Organizational Status
Mission & Business Strategy
Direction
R & D
Antiviral Agent
Research Projects
Pipeline
Company News
Publicity
Investment Information
Investment
Information
Notice
Financial Information
Investment Inquiry
Mission & Business Strategy | ImmuneMed
Mission & Business Strategy
Home
Company
Company
R & D
Company News
Investment Information
Mission & Business Strategy
Company Introduction
CEO Greeting
Organizational Status
Mission & Business Strategy
Direction
Mission & Vision
Mission
Contribution to the healthy life of mankind liberated from infectious diseases
Vision
Global biotech specializing in treatment of infectious diseases
Business Strategy
The pursuit of
technology excellence
in new-drug development
Boost the corporate value by
developing antiviral drugs
and achieving
licensing-out
Early clinical development and rapid securing of certifications/approvals by territorials
Expansion of indications including Chronic Hepatitis B, Influenza-Induced Pneumonia, and Rheumatoid Arthritis
Out-licensing, R&D collaboration, and development pipeline expansion
Stable expansion of production/distribution channels by strengthening CMO, KOL network, and marketing partners